APO Research
Talk to an analyst

APO RESEARCH · REPORT

Food Immunomodulator

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Food Immunomodulator Market Outlook and Growth Opportunities 2026

1 January 2026213 pages

Choose your research edition.

Industry ResearchFood Immunomodulator Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Food Immunomodulator Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Food Immunomodulator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Food Immunomodulator Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Food Immunomodulator Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Food Immunomodulator market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Food Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Food Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Food Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Food Immunomodulator market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Food Immunomodulator market include Danone SA, Nestle SA, Yakult Honsha Co.. Ltd., ADM, Kerry Group, Cargill Inc., IFF, DSM and Chr Hansen Holding A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Food Immunomodulator market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Food Immunomodulator and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Food Immunomodulator sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Food Immunomodulator market size, projected growth trends, production technologies, key applications, and end-use industries.

Food Immunomodulator Segment by Company

Danone SA

Nestle SA

Yakult Honsha Co.. Ltd.

ADM

Kerry Group

Cargill Inc.

IFF

DSM

Chr Hansen Holding A/S

Ingredion inc.

Sabinsa Corporation

BASF

Lonza

BioGaia

Lallemand Inc.

Tate and Lyle

Glanbia Nutritionals

Symbiotec

Amway Corporation

Bio-Thera Solutions Ltd.

Stratu

Nutrition

Food Immunomodulator Segment by Type

Powder

Tablets

Capsules

Other

Food Immunomodulator Segment by Application

Supermarket

Specialty Store

Online Sales

Other

Food Immunomodulator Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Food Immunomodulator status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Food Immunomodulator market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Food Immunomodulator significant trends, drivers, influence factors in global and regions.

6. To analyze Food Immunomodulator competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Food Immunomodulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Food Immunomodulator and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Food Immunomodulator.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Food Immunomodulator market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Food Immunomodulator industry.

Chapter 3: Detailed analysis of Food Immunomodulator manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Food Immunomodulator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Food Immunomodulator in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Food Immunomodulator Industry Trends Table 2. Food Immunomodulator Industry Drivers Table 3. Food Immunomodulator Industry Opportunities and Challenges Table 4. Food Immunomodulator Industry Restraints Table 5. Global Food Immunomodulator Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Food Immunomodulator Revenue Share by Company (2021-2026) Table 7. Global Food Immunomodulator Sales Volume by Company (kt) & (2021-2026) Table 8. Global Food Immunomodulator Sales Volume Share by Company (2021-2026) Table 9. Global Food Immunomodulator Average Price (USD/t) of Company (2021-2026) Table 10. Global Food Immunomodulator Company Ranking, (2024-2026) & (USD Million) Table 11. Global Food Immunomodulator Key Company Manufacturing Base & Headquarters Table 12. Global Food Immunomodulator Company, Product Type & Application Table 13. Global Food Immunomodulator Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Food Immunomodulator by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Powder Table 18. Significant Companies of Tablets Table 19. Significant Companies of Capsules Table 20. Significant Companies of Other Table 21. Global Food Immunomodulator Sales Volume by Type 2021 VS 2025 VS 2032 (kt) Table 22. Global Food Immunomodulator Sales Volume by Type (2021-2026) & (kt) Table 23. Global Food Immunomodulator Sales Volume by Type (2027-2032) & (kt) Table 24. Global Food Immunomodulator Sales Volume Share by Type (2021-2026) Table 25. Global Food Immunomodulator Sales Volume Share by Type (2027-2032) Table 26. Global Food Immunomodulator Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Food Immunomodulator Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Food Immunomodulator Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Food Immunomodulator Sales Value Share by Type (2021-2026) Table 30. Global Food Immunomodulator Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Supermarket Table 32. Significant Companies of Specialty Store Table 33. Significant Companies of Online Sales Table 34. Significant Companies of Other Table 35. Global Food Immunomodulator Sales Volume by Application 2021 VS 2025 VS 2032 (kt) Table 36. Global Food Immunomodulator Sales Volume by Application (2021-2026) & (kt) Table 37. Global Food Immunomodulator Sales Volume by Application (2027-2032) & (kt) Table 38. Global Food Immunomodulator Sales Volume Share by Application (2021-2026) Table 39. Global Food Immunomodulator Sales Volume Share by Application (2027-2032) Table 40. Global Food Immunomodulator Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Food Immunomodulator Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Food Immunomodulator Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Food Immunomodulator Sales Value Share by Application (2021-2026) Table 44. Global Food Immunomodulator Sales Value Share by Application (2027-2032) Table 45. Global Food Immunomodulator Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 46. Global Food Immunomodulator Sales by Region (2021-2026) & (kt) Table 47. Global Food Immunomodulator Sales Market Share by Region (2021-2026) Table 48. Global Food Immunomodulator Sales by Region (2027-2032) & (kt) Table 49. Global Food Immunomodulator Sales Market Share by Region (2027-2032) Table 50. Global Food Immunomodulator Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Food Immunomodulator Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Food Immunomodulator Sales Value Share by Region (2021-2026) Table 53. Global Food Immunomodulator Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Food Immunomodulator Sales Value Share by Region (2027-2032) Table 55. Global Food Immunomodulator Market Average Price (USD/t) by Region (2021-2026) Table 56. Global Food Immunomodulator Market Average Price (USD/t) by Region (2027-2032) Table 57. Global Food Immunomodulator Sales by Country: 2021 VS 2025 VS 2032 (kt) Table 58. Global Food Immunomodulator Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Food Immunomodulator Sales by Country (2021-2026) & (kt) Table 60. Global Food Immunomodulator Sales Market Share by Country (2021-2026) Table 61. Global Food Immunomodulator Sales by Country (2027-2032) & (kt) Table 62. Global Food Immunomodulator Sales Market Share by Country (2027-2032) Table 63. Global Food Immunomodulator Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Food Immunomodulator Sales Value Market Share by Country (2021-2026) Table 65. Global Food Immunomodulator Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Food Immunomodulator Sales Value Market Share by Country (2027-2032) Table 67. Danone SA Company Information Table 68. Danone SA Business Overview Table 69. Danone SA Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 70. Danone SA Food Immunomodulator Product Portfolio Table 71. Danone SA Recent Development Table 72. Nestle SA Company Information Table 73. Nestle SA Business Overview Table 74. Nestle SA Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Nestle SA Food Immunomodulator Product Portfolio Table 76. Nestle SA Recent Development Table 77. Yakult Honsha Co.. Ltd. Company Information Table 78. Yakult Honsha Co.. Ltd. Business Overview Table 79. Yakult Honsha Co.. Ltd. Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. Yakult Honsha Co.. Ltd. Food Immunomodulator Product Portfolio Table 81. Yakult Honsha Co.. Ltd. Recent Development Table 82. ADM Company Information Table 83. ADM Business Overview Table 84. ADM Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. ADM Food Immunomodulator Product Portfolio Table 86. ADM Recent Development Table 87. Kerry Group Company Information Table 88. Kerry Group Business Overview Table 89. Kerry Group Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 90. Kerry Group Food Immunomodulator Product Portfolio Table 91. Kerry Group Recent Development Table 92. Cargill Inc. Company Information Table 93. Cargill Inc. Business Overview Table 94. Cargill Inc. Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 95. Cargill Inc. Food Immunomodulator Product Portfolio Table 96. Cargill Inc. Recent Development Table 97. IFF Company Information Table 98. IFF Business Overview Table 99. IFF Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 100. IFF Food Immunomodulator Product Portfolio Table 101. IFF Recent Development Table 102. DSM Company Information Table 103. DSM Business Overview Table 104. DSM Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 105. DSM Food Immunomodulator Product Portfolio Table 106. DSM Recent Development Table 107. Chr Hansen Holding A/S Company Information Table 108. Chr Hansen Holding A/S Business Overview Table 109. Chr Hansen Holding A/S Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 110. Chr Hansen Holding A/S Food Immunomodulator Product Portfolio Table 111. Chr Hansen Holding A/S Recent Development Table 112. Ingredion inc. Company Information Table 113. Ingredion inc. Business Overview Table 114. Ingredion inc. Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 115. Ingredion inc. Food Immunomodulator Product Portfolio Table 116. Ingredion inc. Recent Development Table 117. Sabinsa Corporation Company Information Table 118. Sabinsa Corporation Business Overview Table 119. Sabinsa Corporation Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 120. Sabinsa Corporation Food Immunomodulator Product Portfolio Table 121. Sabinsa Corporation Recent Development Table 122. BASF Company Information Table 123. BASF Business Overview Table 124. BASF Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 125. BASF Food Immunomodulator Product Portfolio Table 126. BASF Recent Development Table 127. Lonza Company Information Table 128. Lonza Business Overview Table 129. Lonza Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 130. Lonza Food Immunomodulator Product Portfolio Table 131. Lonza Recent Development Table 132. BioGaia Company Information Table 133. BioGaia Business Overview Table 134. BioGaia Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 135. BioGaia Food Immunomodulator Product Portfolio Table 136. BioGaia Recent Development Table 137. Lallemand Inc. Company Information Table 138. Lallemand Inc. Business Overview Table 139. Lallemand Inc. Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 140. Lallemand Inc. Food Immunomodulator Product Portfolio Table 141. Lallemand Inc. Recent Development Table 142. Tate and Lyle Company Information Table 143. Tate and Lyle Business Overview Table 144. Tate and Lyle Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 145. Tate and Lyle Food Immunomodulator Product Portfolio Table 146. Tate and Lyle Recent Development Table 147. Glanbia Nutritionals Company Information Table 148. Glanbia Nutritionals Business Overview Table 149. Glanbia Nutritionals Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 150. Glanbia Nutritionals Food Immunomodulator Product Portfolio Table 151. Glanbia Nutritionals Recent Development Table 152. Symbiotec Company Information Table 153. Symbiotec Business Overview Table 154. Symbiotec Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 155. Symbiotec Food Immunomodulator Product Portfolio Table 156. Symbiotec Recent Development Table 157. Amway Corporation Company Information Table 158. Amway Corporation Business Overview Table 159. Amway Corporation Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 160. Amway Corporation Food Immunomodulator Product Portfolio Table 161. Amway Corporation Recent Development Table 162. Bio-Thera Solutions Ltd. Company Information Table 163. Bio-Thera Solutions Ltd. Business Overview Table 164. Bio-Thera Solutions Ltd. Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 165. Bio-Thera Solutions Ltd. Food Immunomodulator Product Portfolio Table 166. Bio-Thera Solutions Ltd. Recent Development Table 167. Stratu Company Information Table 168. Stratu Business Overview Table 169. Stratu Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 170. Stratu Food Immunomodulator Product Portfolio Table 171. Stratu Recent Development Table 172. Nutrition Company Information Table 173. Nutrition Business Overview Table 174. Nutrition Food Immunomodulator Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 175. Nutrition Food Immunomodulator Product Portfolio Table 176. Nutrition Recent Development Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Food Immunomodulator Distributors List Table 180. Food Immunomodulator Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Food Immunomodulator Product Image Figure 2. Global Food Immunomodulator Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Food Immunomodulator Sales Value (2021-2032) & (US$ Million) Figure 4. Global Food Immunomodulator Sales (2021-2032) & (kt) Figure 5. Global Food Immunomodulator Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Food Immunomodulator Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Powder Image Figure 10. Tablets Image Figure 11. Capsules Image Figure 12. Other Image Figure 13. Global Food Immunomodulator Sales Volume by Type (2021 VS 2025 VS 2032) & (kt) Figure 14. Global Food Immunomodulator Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Food Immunomodulator Sales Volume Share by Type (2021-2032) Figure 16. Global Food Immunomodulator Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Food Immunomodulator Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Food Immunomodulator Sales Value Share by Type (2021-2032) Figure 19. Supermarket Image Figure 20. Specialty Store Image Figure 21. Online Sales Image Figure 22. Other Image Figure 23. Global Food Immunomodulator Sales Volume by Application (2021 VS 2025 VS 2032) & (kt) Figure 24. Global Food Immunomodulator Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Food Immunomodulator Sales Volume Share by Application (2021-2032) Figure 26. Global Food Immunomodulator Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Food Immunomodulator Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Food Immunomodulator Sales Value Share by Application (2021-2032) Figure 29. Global Food Immunomodulator Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 30. Global Food Immunomodulator Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Food Immunomodulator Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Food Immunomodulator Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Food Immunomodulator Sales Value (2021-2032) & (US$ Million) Figure 34. North America Food Immunomodulator Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Food Immunomodulator Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Food Immunomodulator Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Food Immunomodulator Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Food Immunomodulator Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Food Immunomodulator Sales Value (2021-2032) & (US$ Million) Figure 40. South America Food Immunomodulator Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Food Immunomodulator Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Food Immunomodulator Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Food Immunomodulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Food Immunomodulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Food Immunomodulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Food Immunomodulator Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Food Immunomodulator Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Tablets
  • Capsules
  • Other
Applications
  • Supermarket
  • Specialty Store
  • Online Sales
  • Other
Companies covered
  • Danone SA
  • Nestle SA
  • Yakult Honsha Co.. Ltd.
  • ADM
  • Kerry Group
  • Cargill Inc.
  • IFF
  • DSM
  • Chr Hansen Holding A/S
  • Ingredion inc.
  • Sabinsa Corporation
  • BASF
  • Lonza
  • BioGaia
  • Lallemand Inc.
  • Tate and Lyle
  • Glanbia Nutritionals
  • Symbiotec
  • Amway Corporation
  • Bio-Thera Solutions Ltd.
  • Stratu
  • Nutrition

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Food Immunomodulator Sales Value (2021-2032)
  4. 1.2.2 Global Food Immunomodulator Sales Volume (2021-2032)
  5. 1.2.3 Global Food Immunomodulator Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Food Immunomodulator Market Dynamics
  1. 2.1 Food Immunomodulator Industry Trends
  2. 2.2 Food Immunomodulator Industry Drivers
  3. 2.3 Food Immunomodulator Industry Opportunities and Challenges
  4. 2.4 Food Immunomodulator Industry Restraints
3 Food Immunomodulator Market by Company
  1. 3.1 Global Food Immunomodulator Company Revenue Ranking in 2025
  2. 3.2 Global Food Immunomodulator Revenue by Company (2021-2026)
  3. 3.3 Global Food Immunomodulator Sales Volume by Company (2021-2026)
  4. 3.4 Global Food Immunomodulator Average Price by Company (2021-2026)
  5. 3.5 Global Food Immunomodulator Company Ranking (2024-2026)
  6. 3.6 Global Food Immunomodulator Company Manufacturing Base and Headquarters
  7. 3.7 Global Food Immunomodulator Company Product Type and Application
  8. 3.8 Global Food Immunomodulator Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Food Immunomodulator Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Food Immunomodulator Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Food Immunomodulator Market by Type
  1. 4.1 Food Immunomodulator Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Tablets
  4. 4.1.3 Capsules
  5. 4.1.4 Other
  6. 4.2 Global Food Immunomodulator Sales Volume by Type
  7. 4.2.1 Global Food Immunomodulator Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Food Immunomodulator Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Food Immunomodulator Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Food Immunomodulator Sales Value by Type
  11. 4.3.1 Global Food Immunomodulator Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Food Immunomodulator Sales Value by Type (2021-2032)
  13. 4.3.3 Global Food Immunomodulator Sales Value Share by Type (2021-2032)
5 Food Immunomodulator Market by Application
  1. 5.1 Food Immunomodulator Application Introduction
  2. 5.1.1 Supermarket
  3. 5.1.2 Specialty Store
  4. 5.1.3 Online Sales
  5. 5.1.4 Other
  6. 5.2 Global Food Immunomodulator Sales Volume by Application
  7. 5.2.1 Global Food Immunomodulator Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Food Immunomodulator Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Food Immunomodulator Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Food Immunomodulator Sales Value by Application
  11. 5.3.1 Global Food Immunomodulator Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Food Immunomodulator Sales Value by Application (2021-2032)
  13. 5.3.3 Global Food Immunomodulator Sales Value Share by Application (2021-2032)
6 Food Immunomodulator Regional Sales and Value Analysis
  1. 6.1 Global Food Immunomodulator Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Food Immunomodulator Sales by Region (2021-2032)
  3. 6.2.1 Global Food Immunomodulator Sales by Region: 2021-2026
  4. 6.2.2 Global Food Immunomodulator Sales by Region (2027-2032)
  5. 6.3 Global Food Immunomodulator Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Food Immunomodulator Sales Value by Region (2021-2032)
  7. 6.4.1 Global Food Immunomodulator Sales Value by Region: 2021-2026
  8. 6.4.2 Global Food Immunomodulator Sales Value by Region (2027-2032)
  9. 6.5 Global Food Immunomodulator Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Food Immunomodulator Sales Value (2021-2032)
  12. 6.6.2 North America Food Immunomodulator Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Food Immunomodulator Sales Value (2021-2032)
  15. 6.7.2 Europe Food Immunomodulator Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Food Immunomodulator Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Food Immunomodulator Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Food Immunomodulator Sales Value (2021-2032)
  21. 6.9.2 South America Food Immunomodulator Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Food Immunomodulator Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Food Immunomodulator Sales Value Share by Country, 2025 VS 2032
7 Food Immunomodulator Country-level Sales and Value Analysis
  1. 7.1 Global Food Immunomodulator Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Food Immunomodulator Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Food Immunomodulator Sales by Country (2021-2032)
  4. 7.3.1 Global Food Immunomodulator Sales by Country (2021-2026)
  5. 7.3.2 Global Food Immunomodulator Sales by Country (2027-2032)
  6. 7.4 Global Food Immunomodulator Sales Value by Country (2021-2032)
  7. 7.4.1 Global Food Immunomodulator Sales Value by Country (2021-2026)
  8. 7.4.2 Global Food Immunomodulator Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Food Immunomodulator Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Food Immunomodulator Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Food Immunomodulator Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Food Immunomodulator Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Food Immunomodulator Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Food Immunomodulator Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Food Immunomodulator Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Food Immunomodulator Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Food Immunomodulator Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Food Immunomodulator Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Food Immunomodulator Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Food Immunomodulator Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Food Immunomodulator Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Food Immunomodulator Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Food Immunomodulator Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Food Immunomodulator Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Food Immunomodulator Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Food Immunomodulator Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Food Immunomodulator Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Food Immunomodulator Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Food Immunomodulator Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Food Immunomodulator Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Food Immunomodulator Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Food Immunomodulator Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Food Immunomodulator Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Food Immunomodulator Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Food Immunomodulator Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Food Immunomodulator Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Food Immunomodulator Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Food Immunomodulator Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Danone SA
  2. 8.1.1 Danone SA Company Information
  3. 8.1.2 Danone SA Business Overview
  4. 8.1.3 Danone SA Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Danone SA Food Immunomodulator Product Portfolio
  6. 8.1.5 Danone SA Recent Developments
  7. 8.2 Nestle SA
  8. 8.2.1 Nestle SA Company Information
  9. 8.2.2 Nestle SA Business Overview
  10. 8.2.3 Nestle SA Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Nestle SA Food Immunomodulator Product Portfolio
  12. 8.2.5 Nestle SA Recent Developments
  13. 8.3 Yakult Honsha Co.. Ltd.
  14. 8.3.1 Yakult Honsha Co.. Ltd. Company Information
  15. 8.3.2 Yakult Honsha Co.. Ltd. Business Overview
  16. 8.3.3 Yakult Honsha Co.. Ltd. Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yakult Honsha Co.. Ltd. Food Immunomodulator Product Portfolio
  18. 8.3.5 Yakult Honsha Co.. Ltd. Recent Developments
  19. 8.4 ADM
  20. 8.4.1 ADM Company Information
  21. 8.4.2 ADM Business Overview
  22. 8.4.3 ADM Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ADM Food Immunomodulator Product Portfolio
  24. 8.4.5 ADM Recent Developments
  25. 8.5 Kerry Group
  26. 8.5.1 Kerry Group Company Information
  27. 8.5.2 Kerry Group Business Overview
  28. 8.5.3 Kerry Group Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kerry Group Food Immunomodulator Product Portfolio
  30. 8.5.5 Kerry Group Recent Developments
  31. 8.6 Cargill Inc.
  32. 8.6.1 Cargill Inc. Company Information
  33. 8.6.2 Cargill Inc. Business Overview
  34. 8.6.3 Cargill Inc. Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cargill Inc. Food Immunomodulator Product Portfolio
  36. 8.6.5 Cargill Inc. Recent Developments
  37. 8.7 IFF
  38. 8.7.1 IFF Company Information
  39. 8.7.2 IFF Business Overview
  40. 8.7.3 IFF Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 IFF Food Immunomodulator Product Portfolio
  42. 8.7.5 IFF Recent Developments
  43. 8.8 DSM
  44. 8.8.1 DSM Company Information
  45. 8.8.2 DSM Business Overview
  46. 8.8.3 DSM Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 DSM Food Immunomodulator Product Portfolio
  48. 8.8.5 DSM Recent Developments
  49. 8.9 Chr Hansen Holding A/S
  50. 8.9.1 Chr Hansen Holding A/S Company Information
  51. 8.9.2 Chr Hansen Holding A/S Business Overview
  52. 8.9.3 Chr Hansen Holding A/S Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Chr Hansen Holding A/S Food Immunomodulator Product Portfolio
  54. 8.9.5 Chr Hansen Holding A/S Recent Developments
  55. 8.10 Ingredion inc.
  56. 8.10.1 Ingredion inc. Company Information
  57. 8.10.2 Ingredion inc. Business Overview
  58. 8.10.3 Ingredion inc. Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ingredion inc. Food Immunomodulator Product Portfolio
  60. 8.10.5 Ingredion inc. Recent Developments
  61. 8.11 Sabinsa Corporation
  62. 8.11.1 Sabinsa Corporation Company Information
  63. 8.11.2 Sabinsa Corporation Business Overview
  64. 8.11.3 Sabinsa Corporation Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sabinsa Corporation Food Immunomodulator Product Portfolio
  66. 8.11.5 Sabinsa Corporation Recent Developments
  67. 8.12 BASF
  68. 8.12.1 BASF Company Information
  69. 8.12.2 BASF Business Overview
  70. 8.12.3 BASF Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 BASF Food Immunomodulator Product Portfolio
  72. 8.12.5 BASF Recent Developments
  73. 8.13 Lonza
  74. 8.13.1 Lonza Company Information
  75. 8.13.2 Lonza Business Overview
  76. 8.13.3 Lonza Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Lonza Food Immunomodulator Product Portfolio
  78. 8.13.5 Lonza Recent Developments
  79. 8.14 BioGaia
  80. 8.14.1 BioGaia Company Information
  81. 8.14.2 BioGaia Business Overview
  82. 8.14.3 BioGaia Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 BioGaia Food Immunomodulator Product Portfolio
  84. 8.14.5 BioGaia Recent Developments
  85. 8.15 Lallemand Inc.
  86. 8.15.1 Lallemand Inc. Company Information
  87. 8.15.2 Lallemand Inc. Business Overview
  88. 8.15.3 Lallemand Inc. Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Lallemand Inc. Food Immunomodulator Product Portfolio
  90. 8.15.5 Lallemand Inc. Recent Developments
  91. 8.16 Tate and Lyle
  92. 8.16.1 Tate and Lyle Company Information
  93. 8.16.2 Tate and Lyle Business Overview
  94. 8.16.3 Tate and Lyle Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Tate and Lyle Food Immunomodulator Product Portfolio
  96. 8.16.5 Tate and Lyle Recent Developments
  97. 8.17 Glanbia Nutritionals
  98. 8.17.1 Glanbia Nutritionals Company Information
  99. 8.17.2 Glanbia Nutritionals Business Overview
  100. 8.17.3 Glanbia Nutritionals Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Glanbia Nutritionals Food Immunomodulator Product Portfolio
  102. 8.17.5 Glanbia Nutritionals Recent Developments
  103. 8.18 Symbiotec
  104. 8.18.1 Symbiotec Company Information
  105. 8.18.2 Symbiotec Business Overview
  106. 8.18.3 Symbiotec Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Symbiotec Food Immunomodulator Product Portfolio
  108. 8.18.5 Symbiotec Recent Developments
  109. 8.19 Amway Corporation
  110. 8.19.1 Amway Corporation Company Information
  111. 8.19.2 Amway Corporation Business Overview
  112. 8.19.3 Amway Corporation Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Amway Corporation Food Immunomodulator Product Portfolio
  114. 8.19.5 Amway Corporation Recent Developments
  115. 8.20 Bio-Thera Solutions Ltd.
  116. 8.20.1 Bio-Thera Solutions Ltd. Company Information
  117. 8.20.2 Bio-Thera Solutions Ltd. Business Overview
  118. 8.20.3 Bio-Thera Solutions Ltd. Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Bio-Thera Solutions Ltd. Food Immunomodulator Product Portfolio
  120. 8.20.5 Bio-Thera Solutions Ltd. Recent Developments
  121. 8.21 Stratu
  122. 8.21.1 Stratu Company Information
  123. 8.21.2 Stratu Business Overview
  124. 8.21.3 Stratu Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Stratu Food Immunomodulator Product Portfolio
  126. 8.21.5 Stratu Recent Developments
  127. 8.22 Nutrition
  128. 8.22.1 Nutrition Company Information
  129. 8.22.2 Nutrition Business Overview
  130. 8.22.3 Nutrition Food Immunomodulator Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Nutrition Food Immunomodulator Product Portfolio
  132. 8.22.5 Nutrition Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Food Immunomodulator Value Chain Analysis
  2. 9.1.1 Food Immunomodulator Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Food Immunomodulator Sales Mode & Process
  6. 9.2 Food Immunomodulator Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Food Immunomodulator Distributors
  9. 9.2.3 Food Immunomodulator Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst